Delivery Order SPE2DB20D3303-SPE2DB25FA0AR

Award Date 6/10/25
Potential Completion Date 7/2/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $11,895.72 and covers the delivery of Inlyta 5 mg tablets. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,161,311 units of the pharmaceutical product Inlyta 1 mg Tablet in quantities of 180 tablets per bottle. The contract has a ceiling value of $23,847.20 and a period of performance through May 28, 2025. The contract is a firm fixed-price delivery order, with no...
This is a $23,847.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INLYTA 1 MG TABLET 180S, a pharmaceutical product, with a period of performance through June 10, 2025. Amerisourcebergen Drug Corp is also the holder of a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,895.72, is a Firm Fixed Price delivery order for the pharmaceutical product Inlyta 5 mg tablet. The contract has an ultimate completion date of April 29, 2025. Amerisourcebergen is the prime contractor on this award, and the contract is not designated as a set-aside. The company holds a...
This is a $11,039.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 4,565,077,706 tablets of the prescription drug Inlyta (5 mg) to support federal government medical requirements. Amerisourcebergen is a major pharmaceutical distributor that holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,895.72, is for the delivery of 4,568,092,666 units of the pharmaceutical product Inlyta 5 mg tablet. The contract has an ultimate completion date of May 21, 2025 and was awarded on April 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $11,075.39 Firm Fixed Price Delivery Order (SPE2DX15D3201|SPE2DX24F3H0L) is for the supply of 4,565,667,912 INLYTA 1 mg Tablets in quantities of 180s. The contract has no set-aside designation and an ultimate completion date of September 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $22,842.34 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Inlyta 5 mg tablets to support military healthcare programs. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $149,780.56, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs, including medications across therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The award is part of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,247.80 and an ultimate completion date of May 20, 2025. It is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FA0AR
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 tablets of the medication Inlyta 5 mg, with a ceiling value of $11,895.72 and a period of performance through July 2, 2025.

AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside, indicating open competition. As a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems, AmerisourceBergen Drug Corp delivers a wide array of pharmaceutical and medical products through its federal contract awards.

Generated 9/14/25, 1:00 AM